Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) — Analysis Summary
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) has a market cap of $1.78M with year-over-year revenue growth of +99.2%. Net margin stands at -633.6%. The stock trades at a P/E ratio of -0.2.
Key Takeaways
- Revenue changed +99.2% year-over-year
- Net margin of -633.6%
- P/E ratio of -0.2
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, SCNI posted revenue growth of +99.2% and trades at a P/E of -0.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.